Exclusive: Novo's Wegovy and Ozempic US advertising spend doubles rival Eli Lilly, data showsReuters • 01/28/26
Novo Nordisk vs. Viking: Which Obesity Drug Stock is the Safer Bet?Zacks Investment Research • 01/27/26
Oral Wegovy Is Off To An Astronomical Launch. Will It Save Novo Nordisk Stock?Investors Business Daily • 01/23/26
What obesity drugmakers see next in the market: More pills, easier access and drug combinationsCNBC • 01/23/26
Novo Nordisk: How Inspiring New CEO Will Take Fight To Key Rival Eli Lilly In 2026Seeking Alpha • 01/21/26
NVO Expands Aspect Tie-Up to Advance Curative Diabetes Cell TherapiesZacks Investment Research • 01/21/26
Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2026-2030 (Jan 2026)24/7 Wall Street • 01/21/26
Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industryCNBC • 01/20/26
Is Novo Nordisk's Oral Wegovy Driving Strong Early US Demand Already?Zacks Investment Research • 01/19/26